Yung Shin Pharmaceutical Industrial Discontinued
FDA Approved Drugs

Yung Shin Pharmaceutical Industrial Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 5
  • Latest Approval Date Jun 29, 2020
  • Data Source FDA
  • First Approval Date Apr 23, 2007
All
25
View
Discontinued
5
View
RX
20
View
Company Overview

Company

Yung Shin Pharmaceutical Industrial Discontinued

Country

China

Email

Social Profiles

Company Snapshot

Yung Shin Pharmaceutical Industrial Discontinued

Lujia Town, KunShan City, JiangSu Province

China

www.yungshingroup.com/en/category/view.aspx?r=58 View on Map
FDA Approved Drug Records ( 5 records )
2020
06 Mar
Discontinued Application: 202647

Drug Name

GRANISETRON HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)

Approval Date

2020-03-06

202647 / 1

Active Ingredient

GRANISETRON HYDROCHLORIDE

Application Number

202647

Product Number

1

Dosage Form

-

Strength

EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)

Approval Date

2020-03-06

Regulatory Status

Discontinued

2020
29 Jun
Discontinued Application: 202648

Drug Name

GRANISETRON HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE/ML (EQ 1MG BASE/ML)

Approval Date

2020-06-29

202648 / 1

Active Ingredient

GRANISETRON HYDROCHLORIDE

Application Number

202648

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE/ML (EQ 1MG BASE/ML)

Approval Date

2020-06-29

Regulatory Status

Discontinued

2020
29 Jun
Discontinued Application: 202648

Drug Name

GRANISETRON HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 4MG BASE/4ML (EQ 1MG BASE/ML)

Approval Date

2020-06-29

202648 / 2

Active Ingredient

GRANISETRON HYDROCHLORIDE

Application Number

202648

Product Number

2

Dosage Form

-

Strength

EQ 4MG BASE/4ML (EQ 1MG BASE/ML)

Approval Date

2020-06-29

Regulatory Status

Discontinued

2007
23 Apr
Discontinued Application: 77990

Drug Name

ZOLPIDEM TARTRATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2007-04-23

77990 / 1

Active Ingredient

ZOLPIDEM TARTRATE

Application Number

77990

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2007-04-23

Regulatory Status

Discontinued

2007
23 Apr
Discontinued Application: 77990

Drug Name

ZOLPIDEM TARTRATE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2007-04-23

77990 / 2

Active Ingredient

ZOLPIDEM TARTRATE

Application Number

77990

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2007-04-23

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    25 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
5 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

GRANISETRON HYDROCHLORIDE

Application Number

202647

Product Number

1

Active Ingredient

GRANISETRON HYDROCHLORIDE

Dosage Form

-

Strength

EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.